AU2003230873A8 - Targeted cytocidal virionoids for antiangiogenesis - Google Patents

Targeted cytocidal virionoids for antiangiogenesis

Info

Publication number
AU2003230873A8
AU2003230873A8 AU2003230873A AU2003230873A AU2003230873A8 AU 2003230873 A8 AU2003230873 A8 AU 2003230873A8 AU 2003230873 A AU2003230873 A AU 2003230873A AU 2003230873 A AU2003230873 A AU 2003230873A AU 2003230873 A8 AU2003230873 A8 AU 2003230873A8
Authority
AU
Australia
Prior art keywords
virionoids
antiangiogenesis
cytocidal
targeted
targeted cytocidal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003230873A
Other versions
AU2003230873A1 (en
Inventor
Erlinda M Gordon
Frederick L Hall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southern California USC filed Critical University of Southern California USC
Publication of AU2003230873A8 publication Critical patent/AU2003230873A8/en
Publication of AU2003230873A1 publication Critical patent/AU2003230873A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13045—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
    • C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
    • C12N2810/851—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from growth factors; from growth regulators

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003230873A 2002-04-11 2003-04-11 Targeted cytocidal virionoids for antiangiogenesis Abandoned AU2003230873A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37175902P 2002-04-11 2002-04-11
US60/371,759 2002-04-11
PCT/US2003/011142 WO2003087329A2 (en) 2002-04-11 2003-04-11 Targeted cytocidal virionoids for antiangiogenesis

Publications (2)

Publication Number Publication Date
AU2003230873A8 true AU2003230873A8 (en) 2003-10-27
AU2003230873A1 AU2003230873A1 (en) 2003-10-27

Family

ID=29250738

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003230873A Abandoned AU2003230873A1 (en) 2002-04-11 2003-04-11 Targeted cytocidal virionoids for antiangiogenesis

Country Status (2)

Country Link
AU (1) AU2003230873A1 (en)
WO (1) WO2003087329A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037329A (en) * 1994-03-15 2000-03-14 Selective Genetics, Inc. Compositions containing nucleic acids and ligands for therapeutic treatment
WO1998044938A1 (en) * 1997-04-10 1998-10-15 University Of Southern California Modified proteins which bind extracellular matrix components
CA2326407C (en) * 1998-04-29 2012-09-11 University Of Southern California Retroviral vectors including modified envelope escort proteins

Also Published As

Publication number Publication date
WO2003087329A2 (en) 2003-10-23
WO2003087329A3 (en) 2004-10-28
AU2003230873A1 (en) 2003-10-27

Similar Documents

Publication Publication Date Title
GB0221724D0 (en) Endoscope
AU2003237159A8 (en) Treatment for phenylketonuria
GB2383938B (en) Shoe
GB0326486D0 (en) Combination treatment
GB0218526D0 (en) Combination therapy
AU2003215150A8 (en) Therapeutic compounds
IL171887A0 (en) Footswitch
GB0206505D0 (en) Pharmaceutical combination
PL373409A1 (en) Pharmaceutical combination
GB0319182D0 (en) Medical headlight
GB0225873D0 (en) Combination
AU2003230873A8 (en) Targeted cytocidal virionoids for antiangiogenesis
GB0208392D0 (en) Therapeutic compounds
GB0223478D0 (en) Shoe
GB0225874D0 (en) Combination
GB0213383D0 (en) Therapeutic conditions
GB0225875D0 (en) Combination
CA94360S (en) Shoe
GB0220820D0 (en) Treatment
GB0213493D0 (en) Treatment
GB0211098D0 (en) Medical compounds
GB0209176D0 (en) Sure foot
GB0214885D0 (en) Medicament
GB0211377D0 (en) Medicament
GB0212822D0 (en) Shoe advance

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase